Found: 20
Select item for more details and to access through your institution.
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 844, doi. 10.1111/bjh.17093
- By:
- Publication type:
- Article
Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 696, doi. 10.1111/bjh.14689
- By:
- Publication type:
- Article
Teenagers and Adolescents with Hemophilia–Need for a Specific Approach.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5121, doi. 10.3390/jcm13175121
- By:
- Publication type:
- Article
SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 9, p. 3600, doi. 10.1172/JCI80347
- By:
- Publication type:
- Article
IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30941
- By:
- Publication type:
- Article
Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 209, doi. 10.2147/JBM.S304597
- By:
- Publication type:
- Article
Congenital Thrombotic Thrombocytopenic Purpura Associated With Moyamoya Syndrome in a 3-Year-Old Girl: A Case Report.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 4, p. 482, doi. 10.1111/j.1365-2141.2011.08752.x
- By:
- Publication type:
- Article
Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy – results from a single UK centre.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Bleeding control improves after switching to emicizumab: Real‐world experience of 177 children in the PedNet registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 685, doi. 10.1111/hae.15015
- By:
- Publication type:
- Article
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 306, doi. 10.1111/hae.14934
- By:
- Publication type:
- Article
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1291, doi. 10.1111/hae.14847
- By:
- Publication type:
- Article
Long‐term joint outcomes in adolescents with moderate or severe haemophilia A.
- Published in:
- Haemophilia, 2022, v. 28, n. 6, p. 1054, doi. 10.1111/hae.14636
- By:
- Publication type:
- Article
Emicizumab in previously untreated and minimally treated infants.
- Published in:
- Haemophilia, 2022, v. 28, n. 2, p. e61, doi. 10.1111/hae.14485
- By:
- Publication type:
- Article
Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?
- Published in:
- Haemophilia, 2022, v. 28, n. 2, p. e36, doi. 10.1111/hae.14466
- By:
- Publication type:
- Article
Real‐world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e698, doi. 10.1111/hae.14432
- By:
- Publication type:
- Article
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 932, doi. 10.1111/hae.14381
- By:
- Publication type:
- Article
Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e620, doi. 10.1111/hae.14358
- By:
- Publication type:
- Article
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 478, doi. 10.1111/hae.13997
- By:
- Publication type:
- Article